Concourse Financial Group Securities, Inc. Renalytix PLC Transaction History

Concourse Financial Group Securities, Inc.

  • $1.64 Billion
  • Q3 2024
Number of Shares
0
Previous 0 NaN%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024
BUY
$0.21 - $0.45 $0 - $0
0 New
0 $0
Q2 2024

Jul 23, 2024
BUY
$0.23 - $0.93 $0 - $0
0 New
0 $0
Q1 2024

Apr 30, 2024
BUY
$0.26 - $1.47 $0 - $0
0 New
0 $0
Q4 2023

Feb 07, 2024
BUY
$0.33 - $1.61 $0 - $0
0 New
0 $0
Q3 2023

Oct 30, 2023
BUY
$1.51 - $4.01 $0 - $0
0 New
0 $0
Q3 2023

Oct 25, 2023
BUY
$1.51 - $4.01 $0 - $0
0 New
0 $0
Q2 2023

Aug 10, 2023
BUY
$2.0 - $2.92 $0 - $0
0 New
0 $0
Q1 2023

May 15, 2023
BUY
$1.93 - $3.72 $0 - $0
0 New
0 $0
Q4 2022

Jan 30, 2023
BUY
$1.06 - $2.21 $0 - $0
0 New
0 $0
Q3 2022

Nov 15, 2022
BUY
$1.19 - $2.78 $0 - $0
0 New
0 $0
Q2 2022

Aug 09, 2022
BUY
$2.45 - $7.81 $0 - $0
0 New
0 $0
Q1 2022

May 09, 2022
BUY
$5.88 - $15.9 $0 - $0
0 New
0 $0
Q4 2021

Feb 07, 2022
BUY
$13.43 - $27.4 $0 - $0
0 New
0 $0
Q3 2021

Nov 09, 2021
BUY
$17.91 - $34.78 $0 - $0
0 New
0 $0
Q2 2021

Aug 13, 2021
BUY
$23.56 - $34.25 $0 - $0
0 New
0 $0
Q1 2021

May 13, 2021
BUY
$15.25 - $31.13 $0 - $0
0 New
0 $0
Q4 2020

Feb 02, 2021
BUY
$10.69 - $16.0 $0 - $0
0 New
0 $0
Q3 2020

Nov 13, 2020
BUY
$10.18 - $17.3 $0 - $0
0 New
0 $0

Others Institutions Holding RNLX

# of Institutions
29
Shares Held
3.91M
Call Options Held
13.7K
Put Options Held
0
View Full List

About Renalytix plc

RNLX Quotes by TradingView
  • Ticker RNLX
  • Exchange OTC
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 37,445,900
  • Market Cap $5.62M
  • Description
  • Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. The company offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics and personalized patient data ...
More about RNLX
Track This Portfolio

Track Concourse Financial Group Securities, Inc. Portfolio

Follow Concourse Financial Group Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email